ACQUITY PREMIER Solution Improves the UPLC-MS Analysis of Deferoxamine – an Iron Chelating Drug
Applications | 2021 | WatersInstrumentation
Iron chelation therapy is essential for managing iron overload and offers immunomodulatory benefits with potential applications in infection control. Accurate analysis of metal-sensitive compounds like deferoxamine is challenged by interactions with metal surfaces in chromatographic systems, leading to peak distortion, variability, and sensitivity loss.
This study compares a conventional UPLC system and column with the ACQUITY PREMIER Solution—incorporating MaxPeak High Performance Surfaces—to evaluate improvements in peak area, reproducibility, and performance across varying mass loads for deferoxamine analysis by UPLC–MS.
Deferoxamine mesylate and thiourea stock solutions were prepared in acetonitrile–water mixtures. Reproducibility was assessed via three consecutive injections of a test mixture containing thiourea as a void marker and deferoxamine in ammonium formate buffer. Calibration involved six concentration levels from 1 to 30 µg/mL. UPLC separations employed a linear acetonitrile gradient over 2.65 minutes with a 5-minute run time, while detection utilized single ion recording on a QDa mass detector.
The standard UPLC system exhibited a 16.8% RSD for deferoxamine peak areas over ten injections and showed increasing peak area with successive injections due to metal surface adsorption. The ACQUITY PREMIER Solution reduced RSD to 2.1% and delivered a 62% higher average peak area (p<0.05). Performance gains were most pronounced at low mass loads (2–5 ng), with peak area increases of ~60%, decreasing to ~32% at 40–60 ng loads.
Surface-engineered UPLC systems are poised to expand applications for metal-sensitive analytes, including basic chelators lacking acidic moieties. Integration with high-throughput platforms and novel surface chemistries will further improve robustness in pharmaceutical, clinical, and environmental laboratories.
The ACQUITY PREMIER Solution significantly improves peak area and reproducibility for deferoxamine analysis, particularly at low analyte loads, by mitigating metal surface interactions. This approach offers a robust platform for reliable quantification of metal-sensitive compounds.
LC/MS, LC/SQ
IndustriesClinical Research
ManufacturerWaters
Summary
Importance of the Topic
Iron chelation therapy is essential for managing iron overload and offers immunomodulatory benefits with potential applications in infection control. Accurate analysis of metal-sensitive compounds like deferoxamine is challenged by interactions with metal surfaces in chromatographic systems, leading to peak distortion, variability, and sensitivity loss.
Aims and Overview of the Study
This study compares a conventional UPLC system and column with the ACQUITY PREMIER Solution—incorporating MaxPeak High Performance Surfaces—to evaluate improvements in peak area, reproducibility, and performance across varying mass loads for deferoxamine analysis by UPLC–MS.
Methodology
Deferoxamine mesylate and thiourea stock solutions were prepared in acetonitrile–water mixtures. Reproducibility was assessed via three consecutive injections of a test mixture containing thiourea as a void marker and deferoxamine in ammonium formate buffer. Calibration involved six concentration levels from 1 to 30 µg/mL. UPLC separations employed a linear acetonitrile gradient over 2.65 minutes with a 5-minute run time, while detection utilized single ion recording on a QDa mass detector.
Instrumentation
- ACQUITY UPLC H-Class QSM with FTN Sample Manager and Column Manager
- ACQUITY PREMIER H-Class QSM with FTN Sample Manager and Column Manager
- ACQUITY PREMIER HSS T3 column, 1.8 µm, 2.1 × 50 mm
- ACQUITY UPLC HSS T3 column, 1.8 µm, 2.1 × 50 mm
- ACQUITY QDa Mass Detector (50–800 Da, positive mode)
- Empower 3 chromatography software
Main Results and Discussion
The standard UPLC system exhibited a 16.8% RSD for deferoxamine peak areas over ten injections and showed increasing peak area with successive injections due to metal surface adsorption. The ACQUITY PREMIER Solution reduced RSD to 2.1% and delivered a 62% higher average peak area (p<0.05). Performance gains were most pronounced at low mass loads (2–5 ng), with peak area increases of ~60%, decreasing to ~32% at 40–60 ng loads.
Benefits and Practical Applications
- Enhanced sensitivity and peak reproducibility without system conditioning or EDTA additives
- Full compatibility with mass spectrometry detection
- Simplified method development and reduced analysis time
Future Trends and Applications
Surface-engineered UPLC systems are poised to expand applications for metal-sensitive analytes, including basic chelators lacking acidic moieties. Integration with high-throughput platforms and novel surface chemistries will further improve robustness in pharmaceutical, clinical, and environmental laboratories.
Conclusion
The ACQUITY PREMIER Solution significantly improves peak area and reproducibility for deferoxamine analysis, particularly at low analyte loads, by mitigating metal surface interactions. This approach offers a robust platform for reliable quantification of metal-sensitive compounds.
Reference
- Mobarra N., Shanaki M., Ehteram H., Nasiri H., Sahmani M., Saeidi M., Goudarzi M., Pourkarim H., Azad M.A. A Review on Iron Chelators in Treatment of Iron Overload Syndromes. Int J Hematol Oncol Stem Cell Res. 2016;10(4):239–247.
- Williams A., Meyer D. Desferrioxamine as Immunomodulatory Agent During Microorganism Infection. Curr Pharm Des. 2009;15:1261–1268.
- Dalamaga M., Karampela I., Mantzoros C.S. Could Iron Chelators Prove to Be Useful as an Adjunct to COVID-19 Treatment Regimens? Metabolism. 2020;108:154260.
- Cramer S.M., Nathanael B., Horvath C. High-Performance Liquid Chromatography of Deferoxamine and Ferrioxamine: Interference by Iron Present in the Chromatographic System. J Chromatogr. 1984;295:405–411.
- Walter T.H., Trudeau M., Simeone J., Rainville P., Patel A.V., Lauber M.A., Kellett J., DeLano M., Brennan K., Boissel C., Birdsall R., Berthelette K. Low Adsorption UPLC Systems and Columns Based on MaxPeak High Performance Surfaces: The ACQUITY PREMIER Solution. Waters White Paper. 2021.
- Walter T.H., Murphy B.J., Jung M.C., Gilar M., Birdsall R.E., Kellett J. Faster Time to Results for Ultra-Performance Liquid Chromatographic Separations of Metal-Sensitive Analytes. Chromatogr Today. 2021;Feb/Mar:40–44.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
MaxPeak Premier Columns - Small Molecule Application Notebook
2023|Waters|Guides
MaxPeak Premier Columns Small Molecule Application Notebook CONTENTS Introduction Non-Specific Adsorption: Unwanted Interactions................................................................................... 3 How Do Scientists Solve This Problem Today?......................................................................................... 4 Precision Chemistry for Particles and Surfaces........................................................................................ 5 Fundamentals Waters™ Premier Standards to Investigate the Inertness of Chromatographic Systems....................................................................................................................................7…
Key words
premier, premiermaxpeak, maxpeakfundamentals, fundamentalshps, hpsnotebook, notebookacquity, acquitycolumns, columnssurfaces, surfacesmetabolomics, metabolomicsmetal, metalpharmaceutical, pharmaceuticalapplications, applicationsread, readapplication, applicationtechnology
USING HYBRID ORGANIC/INORGANIC SURFACE TECHNOLOGY TO MITIGATE ANALYTE INTERACTIONS WITH METAL SURFACES IN UPLC SEPARATIONS OF SMALL MOLECULE PHARMACEUTICALS
2021|Waters|Posters
T6138V USING HYBRID ORGANIC/INORGANIC SURFACE TECHNOLOGY TO MITIGATE ANALYTE INTERACTIONS WITH METAL SURFACES IN UPLC SEPARATIONS OF SMALL MOLECULE PHARMACEUTICALS Thomas H. Walter, Cheryl Boissel, Jennifer M. Nguyen Waters Corporation, Milford, MA 01757 CONTACT INFORMATION: [email protected] The results of the…
Key words
uplc, uplcpremier, premierclozapine, clozapineacquity, acquitysystem, systemcolumn, columnstandard, standardhst, hstmetal, metalpeak, peaksurfaces, surfaceshybrid, hybriddeferoxamine, deferoxamineinteractions, interactionsmesylate
THE IMPORANCE OF MITIGATING ANALYTE INTERACTIONS WITH METAL SURFACES IN HPLC SEPARATIONS OF SMALL MOLECULES
2023|Waters|Posters
THE IMPORANCE OF MITIGATING ANALYTE INTERACTIONS WITH METAL SURFACES IN HPLC SEPARATIONS OF SMALL MOLECULES Thomas H. Walter, Bonnie A. Alden, Kenneth Berthelette, Cheryl Boissel Waters Corporation, Milford, MA 01757 INTRODUCTION RESULTS AND DISCUSSION Interactions of certain analytes with metal…
Key words
uplc, uplchst, hstpremier, premieracquity, acquitymesylate, mesylatesystem, systemmetal, metalhydrocortisone, hydrocortisonecolumn, columnpeak, peaksurfaces, surfacesdeferoxamine, deferoxaminestandard, standardphosphate, phosphateseparations
Using a Systematic Screening Protocol and MaxPeak™ HPS Technology to Develop a UHPLC Method for the Analysis of Deferoxamine and its Forced Degradation Products
2023|Waters|Applications
English Global | Application Note Using a Systematic Screening Protocol and MaxPeak™ HPS Technology to Develop a UHPLC Method for the Analysis of Deferoxamine and its Forced Degradation Products Kenneth D. Berthelette, Jonathan E. Turner, Thomas H. Walter, Kim Haynes…
Key words
deferoxamine, deferoxaminesystematic, systematicforced, forcedhps, hpsmaxpeak, maxpeakprotocol, protocoldegradation, degradationscreening, screeningdevelop, developuhplc, uhplctechnology, technologyproducts, productsits, itsmethod, methodusing